Objective. Evidence of physical function difficulties, such as difficulty rising from a chair, may limit daily walking for people with knee osteoarthritis (OA). The purpose of this study was to identify minimum performance thresholds on clinical tests of physical function predictive to walking ≥6,000 steps/day. This benchmark is known to discriminate people with knee OA who develop functional limitation over time from those who do not. Methods. Using data from the Osteoarthritis Initiative, we quantified daily walking as average steps/day from an accelerometer (Actigraph GT1M) worn for ≥10 hours/day over 1 week. Physical function was quantified using 3 performance-based clinical tests: 5 times sit-to-stand test, walking speed (tested over 20 meters), and 400-meter walk test. To identify minimum performance thresholds for daily walking, we calculated physical function values corresponding to high specificity (80-95%) to predict walking ≥6,000 steps/day. Results. Among 1,925 participants (mean AE SD age 65.1 AE 9.1 years, mean AE SD body mass index 28.4 AE 4.8 kg/m 2 , and 55% female) with valid accelerometer data, 54.9% walked ≥6,000 steps/day. High specificity thresholds of physical function for walking ≥6,000 steps/day ranged 11.4-14.0 seconds on the 5 times sit-to-stand test, 1.13-1.26 meters/second for walking speed, or 315-349 seconds on the 400-meter walk test. Conclusion. Not meeting these minimum performance thresholds on clinical tests of physical function may indicate inadequate physical ability to walk ≥6,000 steps/day for people with knee OA. Rehabilitation may be indicated to address underlying impairments limiting physical function.
INTRODUCTION
Knee osteoarthritis (OA) is the 11th highest contributor to global disability (1) and the most common cause of functional limitation in older adults (2) . People with knee OA often have low levels of physical activity (3) . Physical activity is defined as any energy expenditure above a resting level (3, 4) . Low levels of physical activity are a major problem since regular participation in physical activity lowers the risk of developing future comorbidities, such as cardiovascular disease, diabetes mellitus, and cancer (5, 6) . Daily walking is a most common type of unstructured physical activity in older adults (7) and is recommended for people with knee OA (8) . Evidence suggests that an aerobic walking program reduces knee pain and improves physical function for people with knee OA (9) (10) (11) .
For people with knee OA, a potential barrier to daily walking is difficulty with physical function (12) . For example, difficulty getting out of a chair or limited walking endurance may hinder how often one walks in the real world. However, it is not known whether reduced physical function is associated with less daily walking, i.e., taking fewer steps/day. If so, this would enable the investigation of minimum values of physical function that may be necessary in order to walk at a meaningful level. Little is known regarding the minimum level of physical function predictive for an active lifestyle. In particular, we are interested in identifying levels of physical function predictive to walking ≥6,000 steps/day. We chose this threshold because we previously found walking ≥6,000 steps/day better discriminates between those who did versus those who did not develop functional limitation 2 years later than people with or at high risk of knee OA, more so than walking 10,000 steps/day or 3,000 steps/day (13) . Identifying the minimum physical function predictive to walking ≥6,000 steps/day may help health care providers gauge when limitations in physical function may be a barrier to daily walking in the real world for people with or at high risk of knee OA.
The purpose of this study was to evaluate minimum performance thresholds on standardized clinical tests of physical function predictive of walking ≥6,000 steps/day. We first evaluated the association of physical function with daily walking, then identified levels of physical function that have a high degree of specificity to predict walking ≥6,000 steps/day. We chose high specificity values to conservatively identify physical function levels that do not support walking ≥6,000 steps/ day by reducing the number of false positives, i.e., people who have poor physical function yet walk ≥6,000 steps/day.
MATERIALS AND METHODS
Study participants. We used publicly available data from the Osteoarthritis Initiative (OAI), a large observational prospective cohort of people with or at risk of knee OA. The OAI examines the development and progression of OA in adults with or at high risk of knee OA. Study participants were recruited from clinical sites located in Maryland, Pennsylvania, Rhode Island, and Ohio. Excluded were people with rheumatoid or inflammatory arthritis, a bilateral end-stage disease defined as severe joint space narrowing, or total knee replacements in both knees, and those who used ambulatory aids other than a cane. Institutional review board approval was obtained from all OAI sites. The current analysis used accelerometer data collected on a subcohort of participants at the 48-month followup visit (13) . Figure 1 provides a summary of the number of accelerometer records at the 48-month followup visit and reasons for exclusion from our analytical sample. Of the 2,127 OAI participants who participated in the accelerometer study, 1,925 participants wore the accelerometer for ≥4 valid days and had steps/day data at the 48-month followup visit. Those who participated in the accelerometer study but were not included in the analytic data set (n = 202) had a higher body mass index (BMI), were less educated, and had worse physical function compared to those included in the analytic data set (n = 1,925) (see Supplementary Study outcome. Daily walking was quantified as steps/ day measured using a uniaxial accelerometer (Actigraph GT1M). The Actigraph GT1M is a valid device to quantify physical activity in free-living conditions (14, 15) . Subjects were fitted with the accelerometer above the right hip and were instructed to wear the accelerometer during waking hours for 7 consecutive days. We employed previously published methods to determine valid physical activity records (16) . Briefly, we defined a valid wear day as ≥10 
Significance & Innovations
• The results from our study provide preliminary minimal performance thresholds on clinical tests of physical function that may be predictive to walking ≥6,000 steps/day, an important benchmark of daily walking for people with knee osteoarthritis.
• Based on our results, we identified general heuristic values that can be used in clinical practice. Taking longer than 12 seconds on the 5 times sitto-stand test, walking slower than 1.22 meters/second, or taking longer than 323 seconds to walk 400 meters may signal inadequate physical function predictive to walking ≥6,000 steps/day.
hours of wear time and included participants with ≥4 valid wear days, as this is the minimum time predictive for a reliable estimate of physical activity behavior (17) . Steps/ day were averaged across the available valid days. We categorized people as walking <6,000 steps/day and ≥6,000 steps/day (13).
Study exposures. We used 3 performance-based clinical tests to measure physical function.
Five times sit-to-stand test. Five times sit-to-stand test was used as a correlate for lower extremity functional strength. Participants were instructed to stand from a chair (straight back, flat, level firm seat and seat height of 45 cm in front) and return to sitting 5 times as quickly as possible with arms folded across the chest. Total time (seconds) was measured with a digital stopwatch, and started with initial movement to stand on the first repetition and ended after returning to sitting on the fifth repetition. The 5 times sitto-stand was recorded as the average of 2 trials. Longer time to perform the test was indicative of worse physical function. The 5 times sit-to-stand test has high test-retest reliability (intraclass correlation coefficients [ICC] >0.9) in older adults with symptomatic hip or knee OA (18, 19) .
Walking speed. The 20-meter walk test was used to calculate self-selected walking speed. Participants were instructed to walk at their usual speed over a marked 20-meter course in an unobstructed and dedicated corridor. Timing with a digital stopwatch began at the initial movement from standing at the start and stopped when they crossed the 20-meter mark. Time to complete the walk (seconds) was divided by distance (20 meters) to obtain walking speed in meters/second. The average of 2 trials was recorded, with slower walking speed indicating worse physical function (20) . Measuring walking speed in a walkway has high test-retest reliability (ICC >0.9) in older adults (21, 22) .
400-meter walk test. The 400-meter walk test was administered to quantify walking endurance. Participants who did not complete the 20-meter walk test, or had a resting heart rate >110 or <40 beats per minute, or blood pressure >180 mm Hg systolic and >100 mm Hg diastolic were not allowed to perform the test. The test was conducted on the same course as the 20-meter walk test. Subjects were instructed to complete 10 laps in a clockwise direction at their usual walking pace. Timing using a digital stopwatch began from the initial movement from standing at the start until 10 laps were completed. Total time (seconds) was recorded, with longer time indicating worse physical function. The 400-meter walk test has high test-retest reliability (ICC >0.9) in healthy middle-aged adults (23).
Potential confounders. We considered the following factors as potential confounders based on their association ) computed from weight and height assessment, comorbidity using the modified Charlson comorbidity index (>1 versus none), and intensity of knee pain (0-10 on a visual analog scale, where the participant pointed to a whole number on the card that best describes the pain at its worst, ranging from 0 = "no pain" to 10 = "pain as bad as you can imagine"). These factors were ascertained at the 48-month visit by interview, questionnaire, and/or direct measurement, as appropriate. Statistical analysis. We described the study sample using means and SDs for continuous variables and percentages for categorical variables. To examine the association of steps/day with physical function, we calculated effect estimates using multiple linear regression adjusted for potential confounders, i.e., age, sex, BMI, race, education, knee pain intensity, and comorbidity. Next, we calculated minimum performance thresholds on clinical tests of physical function corresponding to 80%, 85%, 90%, and 95% specificity values to predict walking ≥6,000 steps/day (13) . Specificity was defined as the proportion of participants whose test performance was above (better than) an identified threshold and walked ≥6,000 steps/day divided by the entire analytic sample who walked ≥6,000 steps/day (Table 1) . We chose high specificity cut points in order to minimize false positives, i.e., minimize the number of people below minimum performance thresholds on clinical tests of physical function who walk ≥6,000 steps/day. Hence, we identified inadequate performance on clinical tests of physical function that predicted the inability to walk >6,000 steps/day of daily walking. Lastly, we repeated the analyses restricting our sample to people with radiographic OA (ROA) defined by Kellgren/Lawrence grade ≥2 on radiographs in 1 or both knees, and people with symptomatic OA (SxOA) defined by the presence of ROA and pain, aching, or stiffness on most days of a month during the previous year. Our intention with these subanalyses was to investigate the stability of our findings across samples of people with ROA and SxOA, because the presence of knee OA and/or symptoms may affect the participation in daily walking and physical functioning (12) .
RESULTS
The analytic study sample included 1,925 people who were mean AE SD 65.1 AE 9.1 years of age, with mean AE SD BMI 28.4 AE 4.8 kg/m 2 . Over half were women (55%), the majority (84%) was white, and 66% graduated from high school ( Table 2 ). On average, the participants walked 6,166 AE 2,924 steps/day, with 54% of the study sample walking ≥6,000 steps/day. Average performance on the clinical tests of physical function was 10.5 AE 2.9 seconds on the 5 times sit-tostand test, 1.33 AE 0.21 meters/seconds for walking speed over 20-meter walk test, or 306 AE 54 seconds on the 400-meter walk test.
Worse performance on clinical tests of physical function was associated with taking fewer steps/day after adjustment Figure 2 . Physical function measures that reflect 80%, 85%, 90%, and 95% specificity in all, radiographic osteoarthritis (ROA), and symptomatic (SxOA) participants for the A, 5 times sit-to-stand test, B, walking speed, and C, 400-meter walk test. Specificity was defined as the proportion of people who had less than threshold values of physical function and who walked ≥6,000 steps/day divided by the proportion of people who walked ≥6,000 steps/day.
for potential confounders ( Performance on the clinical tests of physical function corresponding to 80% to 95% specificity to identify those who walked ≥6,000 steps/day ranged from 11.4 to 14.0 seconds on the 5 times sit-to-stand test, 1.13 to 1.26 meters/second for walking speed, or 315 to 349 seconds on the 400-meter walk test (Figure 2 ). After restricting our study sample to participants with ROA, we observed that the thresholds for performance on the clinical tests of physical function to identify those who walked ≥6,000 steps/day were almost identical to the full sample ( Figure 2 ). When restricted to participants with SxOA, we observed that 80-95% specificity thresholds of performance on physical function tests ranged from 12.4 to 15.0 seconds on the 5 times sit-to-stand test, 1.10 to 1.22 meters/second for walking speed, or 322 to 353 seconds on the 400-meter walk test (Figure 2) .
DISCUSSION
In general, we identified preliminary performance thresholds on clinical tests of physical function predictive of walking ≥6,000 steps/day for people with or at high risk of knee OA. Specifically, completing the 5 times sit-to-stand test in less than 11.4 to 14 seconds, walking more than 1.13 to 1.26 meters/second, or completing the 400-meter walk test in less than 315 to 349 seconds corresponds to 80-95% specificity values to predict walking ≥6,000 steps/day. Study subjects who are unable to meet any one of these thresholds may have insufficient physical function to participate in walking more than 6,000 steps/day. We found these thresholds to be similar when analyses were restricted to those with ROA and SxOA. Previous work by White et al has found similar physical activity cut points across all, ROA, and SxOA participants when predicting functional limitation (13) . This indicates that people with or at high risk of knee OA can be similarly screened for insufficient physical function to walk 6,000 steps/day.
The 5 times sit-to-stand test is a practical objective assessment of functional lower extremity strength that is feasible for use by health professionals. The test requires a chair and stopwatch, can be done in a doctor's office, and has minimal risk of injury as patients simply stand from a chair. Eighty percent specificity thresholds for the sit-tostand test were 11.4, 11.6, and 12.4 seconds for all, ROA, and SxOA participants, respectively. There was variability of approximately 1 second among all and SxOA participants, which is not a clinically meaningful difference (i.e., 2.3 seconds) (27) . Therefore, taking longer than 12 seconds to complete the 5 times sit-to-stand test, a general heuristic (i.e., guiding) value that can be used in clinical practice, may indicate inadequate physical function to walk ≥6,000 steps/day. Similar thresholds have been reported in the literature in other populations (18,28-31 ). For instance, community-dwelling older adults who took more than 12 seconds to complete the 5 times sit-to-stand test had double (odds ratio 2.0 [95% CI 1.3, 3.0]) the risk for multiple falls compared with those who took <12 seconds to complete the test (29) . This test requires the use of lower body muscle groups, including knee and hip extensors, hip, knee, and ankle range of motion, and maintaining balance transitioning from sitting to standing (32) . Poor performance, i.e., requiring greater time to complete the test, may reflect the presence of impairments, including lower body pain, inadequate lower body muscle strength, poor balance, or coordination deficits, which also can limit daily walking.
Walking speed is a well-established marker of health, a predictor of morbidity and mortality in older adults (33) , and feasible to test in the clinic (34) . Eighty percent specificity thresholds for the 20-meter walk test were 1.26, 1.25, and 1.22 meters/second for all, ROA, and SxOA participants, respectively. There was variability of approximately 0.04 meters/second among all and SxOA participants, which is not a clinically meaningful difference (i.e., 0.08 meters/second) (35) . Therefore, walking slower than 1.22 meters/second during the 20-meter walk test, a general heuristic value that can be used in clinical practice, may identify people without the capacity to walk ≥6,000 steps/ day. This particular speed threshold is known to be important for community ambulation, as timed crosswalks are set to require a minimum speed of 1.22 meters/second (20, 36) . Hence, the inability to walk at this speed may represent the inability to safely walk in the community. Impairments in several body systems can slow walking speed (37), including vision, lower extremity strength (38, 39) , aerobic capacity (40) , postural control, and proprioception (39) , and can also restrict daily walking (33) .
Walking endurance, like walking speed, is a well-known predictor of future health outcomes, including mobility limitations, disability, and mortality (23, 41, 42) . Eighty percent specificity thresholds for the 400-meter walk test were 315, 314, and 322 seconds for all, ROA, and SxOA participants, respectively. There was variability of approximately 7 seconds among all and SxOA participants, which is not a clinically meaningful difference (i.e., 20-30 seconds) (43) . Therefore, taking longer than 322 seconds or 5.22 minutes to complete the 400-meter walk test, a general heuristic value that can be used in clinical practice, may have inadequate walking endurance to walk ≥6,000 steps/day. This benchmark is similar to that reported by Newman et al, who found community-dwelling older adults who completed the 400-meter walk test in >365 seconds had 3 times greater risk of mortality compared with those who complete the walk in <290 seconds (41) . Impairments in peak aerobic capacity (44) and cardiorespiratory changes (41) can limit walking endurance and daily walking (41, (44) (45) (46) .
One possible implication of our study is that referral to rehabilitation, such as physical therapy, may be of benefit to those with or at risk of knee OA not meeting one or more of these physical function thresholds. Physical therapists assess underlying modifiable impairments that limit physical function, including pain, muscular strength, range of motion, limited cardiorespiratory fitness, and coordination, then use therapeutic exercise and manual techniques to Physical Function Thresholds for Daily Walking in Knee OAtarget underlying impairments (47) . These interventions that are employed by physical therapists are effective to improve physical function in people with knee OA (48, 49) .
Our study has several limitations. First, we employed only 1 definition of daily walking, i.e., 6,000 steps/day, and did not examine thresholds of different intensities of physical activity, such as time spent in light, moderate, or vigorous intensity activity. Future studies should consider intensity-based outcomes to confirm the extent to which our physical function thresholds also apply to time spent in moderate or vigorous intensity activity. Second, most of our sample was white, well-educated, had a low BMI, and performed better on the physical function tests compared to those who participated in the accelerometer study but did not provide sufficient valid data (see Supplementary  Table 1 , available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.1002/acr.23448/ abstract). Thus, caution should be taken when generalizing these results to other populations. Third, the cross-sectional design allowed us to identify a relationship between physical function and physical activity, but not to draw conclusions about causation. Fourth, the 400-meter walk test was only administered to people who cleared a cardiovascular screen (heart rate 40-110 beats per minute, blood pressure <180 mm Hg systolic and <100 mm Hg diastolic, could complete a 20-meter walk test, did not report shortness of breath/angina, or did not have recent hospitalization or surgery), which may affect the 400-meter walk test threshold. In our analytic sample, 60 participants did not clear the cardiovascular screen. Thus, it is likely that participants with compromised cardiovascular symptoms, who may perform worse on a test of endurance, were excluded. Lastly, there is a possibility study subjects chose to not participate in daily walking irrespective of their physical function ability, possibly due to psychosocial barriers, hence the physical function threshold values should be viewed as estimates that have some variability.
Despite these limitations, our study has several strengths. First, we used a large analytic sample with objectively measured physical activity from a well-established cohort. Second, we selected thresholds of physical function that minimized false positives, i.e., people with knee OA who did not meet performance thresholds were highly unlikely to walk ≥6,000 steps/day. Third, we established performance thresholds using clinically feasible measures of physical function that clinicians can employ in the real world.
In conclusion, we identified preliminary thresholds for performance on clinical tests of physical function that may indicate inadequate physical ability to walk at least 6,000 steps/day, which is an important benchmark we previously found to be associated with protection against the development of future functional limitation. Clinicians may consider prioritizing referral to rehabilitation to improve physical function for people with knee OA that are unable to meet these minimum thresholds.
